
In this guide9 sections
- The BAAPS 2024 audit baseline
- Trend 1: The “natural result” preference is now dominant
- Trend 2: Body contouring after GLP-1 weight loss
- Trend 3: Gender-affirming surgery is rising
- Trend 4: Regulation tightening at the lower end of the market
- Trend 5: Specific procedures rising and falling
- Trend 6: Non-surgical alternatives where the evidence supports them
- What is genuinely driving these shifts
- Booking a consultation
Cosmetic surgery trends shift more slowly than fashion, and many of the procedures making headlines on social media are not the procedures actually being performed in volume in UK clinics. The honest picture, drawn from BAAPS national audit data and consultation patterns at our Baker Street clinic, looks different from the TikTok version. Subtle, anatomically driven work is rising; conspicuous, body-altering procedures are flattening or declining. Regulation is tightening at the lower end of the market. And the most disruptive shift of the past three years is not a new operation at all — it is the GLP-1 weight loss medications reshaping who comes through the door for body contouring.
This guide walks through what is genuinely trending in UK cosmetic surgery in 2025-2026, what is fading, and what the underlying drivers are.
The BAAPS 2024 audit baseline
The British Association of Aesthetic Plastic Surgeons publishes an annual audit of UK procedures performed by its members — the most reliable single source of UK-specific data. The 2024 figures showed 27,462 total procedures, with women accounting for 25,663 (93.5%) and men 1,799 (6.5%). The top procedure overall was breast augmentation, followed by liposuction, abdominoplasty, blepharoplasty, and rhinoplasty.
What is notable about these figures is the modest year-on-year movement. Total UK BAAPS volumes have remained broadly stable for several years, with bigger shifts in the type of procedure being requested rather than the overall demand. The headline trends discussed below sit on top of this stable baseline.
Trend 1: The “natural result” preference is now dominant
The single biggest aesthetic shift across the past five years has been the move away from conspicuous, identifiably-altered results toward outcomes that read as natural and proportionate. This is visible across procedures:
- Breast augmentation: implant volume requests have shifted lower. Average implant volumes are 250-350cc rather than the larger sizes that were more common a decade ago. The most common conversation at consultation is now about how to avoid an obviously augmented appearance rather than how to maximise size. See breast augmentation.
- Rhinoplasty: the trend is toward preservation rhinoplasty techniques, which retain the underlying nasal framework and modify it rather than removing structural support. Results are subtler and the recovery is gentler than older “open structural” approaches. See rhinoplasty.
- Facelift: deep plane and extended SMAS techniques have largely replaced skin-only lifts. The results last longer and look less “pulled”. Patients want to look refreshed, not operated-on. See facelift.
- Injectables: the over-filled, “pillow face” appearance that characterised mid-2010s injectable work is now broadly out of fashion. Volumes per session are smaller, treatments are spread over time, and the goal is to look rested rather than visibly volumised.
The underlying driver is partly a generational shift — patients in their 30s and 40s today have grown up watching the conspicuous results of an earlier era age badly, and they want something different — and partly a correction after a period of injectable over-treatment fuelled by Instagram aesthetics.
Trend 2: Body contouring after GLP-1 weight loss
The most consequential change in the past three years has been the rise of GLP-1 receptor agonist medications and the wave of body contouring demand that follows them. Average weight loss is around 15% to 20% of body weight, depending on the medication, over 12-18 months. That magnitude of loss, in patients who often had no realistic prospect of getting there through diet alone, leaves a specific surgical problem: significant skin laxity, sometimes with residual stubborn fat, in a patient at a now-stable lower weight.
The procedures we are increasingly performing on this group:
- Abdominoplasty for abdominal skin redundancy.
- Arm lift (brachioplasty) for upper arm laxity.
- Thigh lift for inner thigh redundancy.
- Breast lift alone or combined with small implants where breast volume has reduced significantly.
- Lower body lift for major circumferential redundancy across abdomen, hips, and buttocks.
- Body contouring after weight loss packages combining multiple stages.
The clinical reality of operating on GLP-1 weight loss patients differs from the post-bariatric pathway. Surgical timing — wait until weight has been stable for at least 6 months — is the same. But the pre-operative nutritional optimisation is generally less complex, and skin quality is often somewhat better. The standard advice is to pause GLP-1 medications for at least one week before surgery, due to delayed gastric emptying affecting anaesthesia safety. See how to lose weight before cosmetic surgery for the full discussion.
Trend 3: Gender-affirming surgery is rising
Demand for gender-affirming cosmetic surgery has risen consistently across the past five years. The dominant procedure type by volume is FTM top surgery — bilateral mastectomy with chest masculinisation — for transmasculine patients. The procedure is well-established, the techniques (double incision with free nipple grafts, periareolar, or keyhole, depending on starting chest characteristics) are mature, and outcomes are consistently good in appropriately selected patients.
The patient population is significantly younger on average than for general cosmetic procedures — typically late teens to early thirties — and the consultation focus is markedly different. There is more emphasis on the patient’s medical and psychosocial readiness pathway, on coordinating with the patient’s wider gender care team where they have one, and on long-term planning. Discounting or “deals” have no place in this work, and we do not offer them.
Trend 4: Regulation tightening at the lower end of the market
The UK has been moving steadily toward tighter regulation of the non-surgical and lower-end cosmetic market across the past five years. The picture as of 2026:
- Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 criminalised the provision of fillers and anti-wrinkle injections to under-18s for cosmetic purposes. The law has been in force for several years and is now being more actively enforced.
- JCCP (Joint Council for Cosmetic Practitioners) registration is being increasingly required by local authority licensing schemes for non-surgical practitioners.
- Local authority licensing schemes for cosmetic procedures (separate from CQC clinical regulation) are expanding. Complaint volumes from these schemes rose sharply during 2023-2024, indicating that the regulatory net is starting to catch problematic providers.
- BAAPS surgery audit data recorded a 44% year-on-year rise in patients presenting with complications from overseas cosmetic surgery — a continuing concern driving advice against medical tourism.
None of this directly affects CQC-regulated consultant surgical practice, which has always operated within a stricter framework. It does, however, affect the wider market context, and patients are increasingly aware of the regulatory distinctions between properly-regulated medical practice and unregulated beauty-industry provision.
Trend 5: Specific procedures rising and falling
Rising in our caseload:
- Labiaplasty and clitoral hood reduction — demand has grown steadily, driven partly by greater openness in discussing intimate concerns and partly by genuine post-pregnancy and post-puberty discomfort that surgery can address effectively.
- Blepharoplasty — including in younger patients (40s, occasionally late 30s) seeking modest upper eyelid refinement rather than dramatic rejuvenation.
- Gynaecomastia surgery — male breast reduction has grown consistently and accounts for a substantial proportion of our male caseload.
- VASER liposuction and 360 liposuction for athletic-definition results in patients who already have good baseline body composition.
- Submental (chin and neck) liposuction, often combined with energy-based skin tightening, for patients in their 40s and 50s.
Falling or stable rather than growing:
- Brazilian butt lift (BBL) — UK demand has cooled following sustained safety concerns and high-profile cases. We continue to perform BBL where clinically appropriate, but the volumes have not grown the way some commentators predicted in 2019-2020.
- Large-volume implants in breast augmentation — falling as the natural-result preference takes hold.
- Buccal fat removal — saw a brief spike in 2022-2023 but demand has moderated as patients absorb the irreversibility and the potential for premature gaunt appearance in later decades.
Trend 6: Non-surgical alternatives where the evidence supports them
The non-surgical market is large and growing, but the picture is uneven. Some non-surgical treatments have credible evidence and produce real results for the right indications; others are oversold to patients who would be better served by surgery or by doing nothing.
What we offer where the evidence supports it:
- Morpheus8 for mild-to-moderate facial and body skin laxity — radiofrequency microneedling with reasonable evidence for collagen stimulation.
- FaceTite and BodyTite for combined mild fat reduction and skin tightening in defined areas.
- Fotona 4D as a gentler skin-tightening option for facial laxity.
- TightSculpting for modest non-surgical fat reduction in small areas with good skin quality.
- Anti-wrinkle injections (botulinum toxin) — well-evidenced for dynamic facial lines.
- Dermal fillers — useful for restoring lost volume in defined areas; far less useful when used to chase a “fuller” appearance beyond what the underlying anatomy supports.
What we do not offer because the evidence does not support it: any of the “fat-melting” injectables and devices marketed by unregulated providers, treatments claiming dramatic results without downtime that defy the underlying biology, and ultrasonic devices marketed with claims that exceed what the published evidence shows.
What is genuinely driving these shifts
Three underlying forces are visible behind the surface trends:
Better-informed patients. The average patient at consultation in 2026 has done substantially more research than the average patient ten years ago. They arrive with specific terminology, specific questions, and realistic expectations more often than in the past. This filters into procedure choice (more accurate matching of procedure to concern), recovery planning (better post-operative compliance), and outcome assessment (more honest self-evaluation).
Generational aesthetic preferences. The patients in their 30s and 40s today have watched the conspicuous results of an earlier cosmetic-surgery era age badly. They want subtler work, more conservative augmentation, results that look natural rather than overtly modified.
Regulatory and economic pressure. The crackdown on unregulated provision is gradually pushing patients toward properly regulated providers — and the increasing recognition that overseas medical tourism has real costs has slowed the outflow of UK patients to Turkey and Eastern Europe. Demand has not disappeared; it has been redistributed.
For a more in-depth look at how social media specifically shapes patient expectations, see cosmetic surgery before-and-after photos on social media.
Booking a consultation
If you are considering cosmetic surgery and want to discuss what the current options look like for your specific concerns, the consultation is the place to start. Call 020 7993 4849 or use the contact form to arrange an in-person consultation at our Baker Street clinic.
Related reading
- Cosmetic surgery before-and-after photos on social media
- How to lose weight before cosmetic surgery
- The dangers of cosmetic surgery tourism
Centre for Surgery · CQC-regulated · GMC-registered surgeons · 95–97 Baker Street, Marylebone, London W1U 6RN · 020 7993 4849 · Book a consultation · Finance available, subject to status
